Practice Leadership
- Peter H. Ehrenberg
- Partner
Chair, Corporate Department
Chair, Corporate Governance & Compliance
Honors & Awards
-
Chambers USA: America's Leading Lawyers for Business: (2012-2013, 2018): Recognised Practitioner, Nationwide category, for Capital Markets: Securitisation.
-
Chambers USA: America's Leading Lawyers for Business (2018): Recognized in the Corporate and Mergers & Acquisitions sections and lauded as the "gold standard" for corporate and M&A law
-
The Best Lawyers in America (2018- 2019): Recognized in the Corporate Law and Real Estate Law sections.
-
New Jersey Super Lawyers (2012-2013, 2015-2018): Recognized for work in Business/Corporate, Closely Held Business and Real Estate: Business
-
Chambers USA: America's Leading Lawyers for Business: (2018): Recognized in the Corporate and Mergers & Acquisitions sections as "Highly Regarded" in New York
-
Chambers USA: America’s Leading Lawyers for Business: (2018): Ranked in Band 1 for Corporate/Mergers & Acquisitions in New Jersey
Practice Leadership
- Peter H. Ehrenberg
- Partner
Chair, Corporate Department
Chair, Corporate Governance & Compliance
Honors & Awards
-
Chambers USA: America's Leading Lawyers for Business: (2012-2013, 2018): Recognised Practitioner, Nationwide category, for Capital Markets: Securitisation.
-
Chambers USA: America's Leading Lawyers for Business (2018): Recognized in the Corporate and Mergers & Acquisitions sections and lauded as the "gold standard" for corporate and M&A law
-
The Best Lawyers in America (2018- 2019): Recognized in the Corporate Law and Real Estate Law sections.
-
New Jersey Super Lawyers (2012-2013, 2015-2018): Recognized for work in Business/Corporate, Closely Held Business and Real Estate: Business
-
Chambers USA: America's Leading Lawyers for Business: (2018): Recognized in the Corporate and Mergers & Acquisitions sections as "Highly Regarded" in New York
-
Chambers USA: America’s Leading Lawyers for Business: (2018): Ranked in Band 1 for Corporate/Mergers & Acquisitions in New Jersey
Corporate
Companies must contend with a constant stream of challenges in today's highly competitive business environment. At different stages they may need to protect intellectual property, develop new infrastructures, acquire or dispose of products or businesses, expand and incentivize their workforce, raise private or public equity or debt, or solidify corporate governance.
Meeting these challenges requires farsightedness, planning, and the support of a proactive, dedicated legal team. Ranked nationally by Chambers USA, our Corporate practice offers the strategic advice and detail-oriented execution companies need across the full spectrum of business formation, financing, growth, and exit transactions. As one of our clients told Chambers USA, "The thing that impressed me the most is that they can provide end-to-end service in any of the issues we are facing. There hasn't been a problem Lowenstein has not been able to solve."
We represent clients in a variety of industries, with a particular emphasis on investment funds, life sciences, and technology. We are very active in representing clients ranging from startups and Fortune 500 companies to private equity and venture funds and their portfolio companies in middle-market M&As, investments, and financing transactions.
Our industry experience and market knowledge allow us to develop and maintain our clients' trust and to help them quickly seize profitable opportunities. We combine exceptional accessibility and responsiveness with a deep understanding of their business. We know that macro- and micro-level concerns determine how, when, and if a company undertakes a given venture. In every transaction, we keep one eye focused on the details and the other on our clients' overarching goals.
EXPERIENCE
-
Represented Foley, Inc., the Caterpillar franchisee for northern New Jersey, Staten Island, and Bermuda, in its acquisition of substantially all assets of Giles & Ransome, Inc., expanding Foley’s Caterpillar territory to include eastern Pennsylvania, southern New Jersey, and northern Delaware.
-
Representing Indorama Ventures Holdings LP (subsidiary of Indorama Ventures Public Company Limited) in a new joint venture between Indorama Ventures Holdings LP, Alpek, S.A.B. de C.V. (BMV: ALFAA), and Far Eastern Investment (Holding) Ltd. (a subsidiary of Far Eastern New Century Corporation (TT: 1402))—entering into an asset purchase agreement with M&G USA Corp. (a subsidiary of M&G Chemicals) to acquire, through a bankruptcy auction, M&G’s Corpus Christi, Texas-based PTA-PET plant. The purchase agreement contemplates a purchase price and capital contributions in the sum of $1.125 billion.
-
Represented Vesey Street Capital Partners (VSCP), as part of the recapitalization of HealthChannels, the parent company of ScribeAmerica. VSCP, a strategic private equity firm dedicated to health care services investments, led the recapitalization alongside HealthChannels’ management team.
-
Represented System One Holdings, LLC’s management team, a leading professional staffing company focused on the nuclear wind and solar industries, in connection with Thomas H. Lee Partners L.P.’s investment in System One.
-
Represented the owners of TGaS Advisors in its acquisition by Trinity Partners
-
ACV Auctions, an advanced online auction that streamlines the buying and selling of inventory between auto dealers, in its $31 million Series C financing led by Bessemer Venture Partners, Tribeca Ventures, SoftBank NY, and Armory Square Ventures. We previously represented ACV Auctions in its $15 million Series B financing.
-
Centivo, a new type of self-funded health plan, in its $34 million Series A financing led by Bain Capital Ventures, with additional investments from F-Prime Capital Partners, Maverick Ventures, Bessemer Venture Partners, Ingleside Investors, Rand Capital, Grand Central Tech Ventures, and Oxeon Investments.
-
Perch, the marketplace for buying and selling homes, in its $30 million Series A financing led by FirstMark Capital, with Juxtapose and Accomplice also participating in the round.
-
Aetion, the software platform company delivering the real-world analytics and evidence needed for biopharma and payers to engage in value-based care, in its $36.4 million Series B financing, in a round led by New Enterprise Associates (NEA) and including, as a new investor, Amgen Ventures, alongside existing investors Flare Capital Partners, Lakestar, and Oxeon Ventures. We previously represented Aetion in is $11.2 million Series A financing led by Flare Capital Partners and joined by Lakestar.
NEWS & INSIGHTS
PUBLICATIONS
- "How Regulation A Updates Could Benefit Smaller Reporting Companies," Corporate Counsel
- "What Can I Find Out About a Company From Its Website?," Bloomberg Law
PRESS MENTIONS
-
January 14, 2019
Valeska Pederson Hintz is quoted in Forbes in which she discusses Slack, a work-messaging tech unicorn, and the company’s plan to forego a traditional initial public offering (IPO) in favor of a direct listing this year. The article describes this as an unconventional move that could encourage other tech unicorn companies to consider a direct listing in lieu of an IPO, though this isn’t likely to become a mainstream trend. Pederson Hintz suggests that large tech unicorns are uniquely positioned to take advantage of a direct listing for their market debut because they are often well-capitalized and have brand recognition. Pederson Hintz states that direct listings are faster and cheaper than traditional IPOs. (subscription required to access article)
-
January 2-7, 2019
Lowenstein’s 2019 promotion of seven lawyers to partner and six to counsel (including three women in each category) is noted in Bloomberg Law – Big Law Business. These promotions are also highlighted in LawFuel, The Deal, and the Commerce and Industry Association of New Jersey’s (CIANJ) Business Beat newsletter, with Lesley P. Adamo, Dmitry Andreev, Marc S. Kurzweil, James B. O’Grady, Eileen Overbaugh, Peter Slocum, and Julie Levinson Werner highlighted as newly elected partners and Brandon Fierro, Joseph G. Jones, Robert Lynn, Brianne Perlman, Nedda N. Salehi, and Leah Satlin listed as promoted to counsel. Gary M. Wingens is quoted regarding the critical role these lawyers will play in the firm’s continued success. View Lowenstein’s news announcement about these promotions.
-
October 15; November 30, 2018; December 18, 2018
StreetInsider.com, The Deal, citybizlist, The PE Hub Network (October 15, 2018; December 18, 2018), MarketWatch, Law360, Global Legal Chronicle, and Business Wire note Lowenstein Sandler as counsel to Cambium Learning Group, Inc. in its $900 million definitive merger agreement with Veritas Capital. (Lowenstein deal team: Steven E. Siesser, Elisia M. Klinka, Brooke A. Gillar, Michael J. Mueller, Lauren M. Troeller, Bianka V. Barraza, Lowell A. Citron, Jeffrey Blumenfeld, Jack Sidorov, Jeffrey M. Shapiro, Steven M. Skolnick, Kate Basmagian, Scott Siegel, Lesley P. Adamo, Sophia Mokotoff, Darren Goodman, Megan Monson, Katie R. Glynn, David W. Field, Michael A. Kaplan, Eric Jesse, Nicholas G. Mehler, Steven M. Hecht, Sean Collier, Edward J. Hunter, Zarema A. Jaramillo, Andrew David Behlmann, and Gina M. Seong.) (subscription required to access certain content) View Lowenstein’s news announcement about this transaction.
-
November 5-12; December 13-19, 2018
MarketWatch, GlobeNewswire, TenLinks, StreetInsider.com, Yahoo! Finance, Digital Engineering, Global Legal Chronicle, and Crain's Detroit Business note Lowenstein Sandler as counsel to Altair Engineering Inc. (Nasdaq: ALTR) in its $176 million acquisition of Datawatch Corporation (Nasdaq: DWCH). (Lowenstein deal team: Peter H. Ehrenberg, Michael J. Mueller, Elizabeth A. Mandle, Justin Gindi, Colin J. Kirby, Valeska Pederson Hintz, Kate Basmagian, Lauren E. Killeen, Darren Goodman, Megan Monson, Brian A. Silikovitz, Sophia Mokotoff, Mark P. Kesslen, Manali Joglekar, Leah Satlin, Jeffrey Blumenfeld, Jack Sidorov, Jeffrey M. Shapiro, Lynda A. Bennett, Eric Jesse, Lowell A. Citron, Lauren M. Troeller, and Erica Perlmutter.) View Lowenstein’s news announcement about this transaction.
-
December 12, 2018
The PE Hub Network, The Deal, and Law360 note Lowenstein Sandler as lead counsel to Cerberus Capital Management, L.P. in its acquisition of Sparton Corporation (NYSE: SPA). (Lowenstein deal team: Marita A. Makinen, Robert G. Minion, Jeffrey Blumenfeld, Mary J. Hildebrand, Nicholas G. Mehler, Christine Osvald-Mruz, Matt Savare, Jeffrey M. Shapiro, James C. Shehan, Michael Walutes, Jack Sidorov, Norman W. Spindel, Stuart S. Yusem, Manali Joglekar, Sabrina Cua, Allison Gabala, Megan Monson, Alex H. Rosenthal, Bryan Sterba, Matthew Tippy, Lauren E. Killeen, and Lauren M. Troeller.) (subscription required to view certain content) View Lowenstein’s news announcement about this transaction.
-
November 30 - December 3, 2018
Business Wire, MarketWatch, Pharmaceutical Business Review, Cosmetics Technology, ABF Journal, Cision PR Newswire, and the Tullahoma News note Lowenstein Sandler as counsel to Crown Laboratories, Inc. (Crown Laboratories) and Hildred Capital Partners, LLC in Crown Laboratories’ acquisition of the North American distribution rights of five OTC consumer brands from GlaxoSmithKline plc (NYSE: GSK). (Lowenstein deal team: Herschel S. Weinstein, Sam E. Khan, Mitchell McDonald, Sunita Patel, James C. Shehan, Matthew P. Hintz, Sofia Kopelevich, Michael A. Buxbaum, Nicholas Gonski, Matthew Tippy, Jeffrey M. Shapiro, and Jack Sidorov. View Lowenstein’s news announcement about this transaction.
-
October 29-December 27, 2018
Reuters, Axios, The PE Hub Network, Food Processing Technology (October 31, 2018; November 2, 2018), Global Legal Chronicle, and just-food.com note Lowenstein Sandler as counsel to Traub Capital LLC in its acquisition of Signature Brands from The Hero Group. (Lowenstein deal team: Michael A. Brosse, Michael J. Mueller, Sabrina Cua, Justin Gindi, Lowell A. Citron, Theodore C. Sica, Nicholas Gonski, Michael Walutes, Nicholas G. Mehler, Matthew P. Hintz, Sofia Kopelevich, Darren Goodman, Megan Monson, Eric Jesse, James C. Shehan, Stuart S. Yusem, and Mitchell McDonald.) View Lowenstein’s news announcement about this transaction.
-
October 10, 2018
StreetInsider.com, MarketWatch, RTTNews, The Advocate, Markets Insider, and Seeking Alpha highlight Lowenstein client Compassionate Care Hospice’s entering a definitive agreement to be acquired by Amedisys, Inc. (Lowenstein deal team: Marita A. Makinen, Annie Nazarian Davydov, James C. Shehan, Michael Walutes, Michael N. Gooen, Darren Goodman, Sophia Mokotoff, Jack Sidorov, and Scott Siegel.) View Lowenstein’s news announcement about this transaction.
-
September 27-30, 2018
Business Wire, Compelo Ltd., and citybizlist note Lowenstein Sandler as legal counsel to Crown Laboratories, Inc. and Hildred Capital Partners, LLC in Crown's acquisition of Bellus Medical, which will become the new Aesthetics Division of Crown Laboratories. (Lowenstein deal team led by Sam E. Khan and Herschel S. Weinstein.)
-
August 15, 2018
The Global Legal Chronicle notes Lowenstein Sandler's representation of Regulatory Professionals, Inc. (RPI) in its acquisition by Premier Research. The write-up lists the Lowenstein team: Steven E. Siesser, Lowell A. Citron, Brooke A. Gillar, Lesley P. Adamo, Eric Jesse, Alexander Brooks, Sophia Mokotoff, Megan Monson, Matthew A. Nemeth, and Sami Najib. View Lowenstein’s news announcement about this transaction.
-
August 14, 2018
CNBC highlights Intapp’s acquisition by DealCloud. Lowenstein was counsel to DealCloud for this transaction. View Lowenstein’s news announcement about this deal.
-
July 30-August 6, 2018
The PE Hub Network, Cision PR Newswire, and FierceBiotech note Lowenstein Sandler as counsel to Regulatory Professionals, Inc. (RPI) in its acquisition by Premier Research. View Lowenstein’s news announcement about this transaction.
-
July 30, 2018
The PE Hub Network and Mergers & Acquisitions note Lowenstein Sandler as counsel to NexPhase Capital, LP in its equity stake investment in Brandt Information Services, LLC.
-
June 26-July 2, 2018
The National Law Journal, Bloomberg Law – Big Law Business, The American Lawyer, the ABA Journal, Law360, the Sun Sentinel, the Houston Business Journal, The Am Law Litigation Daily, Adam Smith, Esq., and LawPundit spotlight the firm’s call (co-authored by Gary M. Wingens and Brad Karp of Paul Weiss and published in The New York Times) for the Trump administration to develop an immediate plan for reunifying over 2,300 children separated from their parents upon entering the United States. The American Lawyer offers a thorough profile of how the Op-Ed came about, from thought process through drafting and execution, with Wingens quoted regarding Lowenstein’s involvement: “We believe this kind of stance is consistent with who we are…It’s who we’ve always been.” Media coverage notes the support of 34 law firms nationwide. (subscription required to access certain articles)
-
June 26-July 2, 2018
Above the Law, Law360, and the New Jersey Law Journal note the firm’s updated associate compensation structure. Above the Law provides a visual breakdown of bonuses for the law school graduating classes of 2010-2017 and also notes the joint Op-Ed coauthored by Gary M. Wingens and Paul Weiss’s Brad Karp, published in The New York Times, which calls on the Trump administration to abide by the rule of law regarding asylum seekers crossing the U.S. border. (subscription required to access certain articles)
-
June 4, 2018
4-traders.com and StreetInsider.com note Lowenstein Sandler as legal co-counsel with Gracin & Marlow, LLP to Aravive Biologics, Inc. in connection with its merger with a wholly owned subsidiary of Versartis, Inc. in an all-stock transaction. (Lowenstein deal team: Alan Wovsaniker and Andrew E. Graw.)
-
May 25, 2018
The PE Hub Network notes Lowenstein Sandler as legal counsel to Fenway Partners and affiliated investors in those entities' acquisition of Iconic Group.
-
March 21, 2018
Reorg Research, Chemical Engineering, and Textile World highlight Lowenstein as the legal advisor to Indorama Ventures Public Company Limited in its joint venture acquisition of M&G Chemicals’s Corpus Christi, Texas-based PTA-PET plant. Lowenstein is also listed as Indorama’s legal advisor in its acquisition of M&G Polimeros Brazil S.A., the largest PET facility in Brazil, by Textile World, Plastic News Europe, and Plastics in Packaging. (subscription required to access Reorg Research article)
-
February 13, 2018
Construction Business Owner highlights Lowenstein’s representation of Foley, Inc. in its acquisition of Ransome CAT.
-
January 25, 2018
Gary M. Wingens and Joseph J.Palermo are quoted in Bloomberg Law – Big Law Business about Joe’s joining Lowenstein as COO and, more broadly, about the growing importance of the COO role in law firms’ strategic growth and direction. Joe’s arrival at the firm was also covered in LawFuel.
-
August 4, 2016
Bloomberg View cites a Forbes Tech article by Ed Zimmerman, Peter Ehrenberg, and Valeska Pederson Hintz on SEC Rule 701 in its discussion of robot funds and bank regulation.
-
February 24, 2015
John D. Hogoboom comments on early 2015 market dynamics in The Deal Pipeline.
-
February 10, 2015
John D. Hogoboom comments on the recent surge in life science offerings in The DealFlow Report.
-
January 20, 2015
John D. Hogoboom comments on the 2015 capital markets outlook for small-cap companies in The DealFlow Report.
-
January 13, 2015
John D. Hogoboom comments on the PIPE market in The Daily Deal.
-
November 4, 2014
John D. Hogoboom discusses the rationale for anti-shorting covenants in PIPE investments in The Deal Pipeline.
-
October 28, 2014
John D. Hogoboom comments in The Deal Pipeline on the current environment for life sciences IPOs.
-
October 28, 2014
John D. Hogoboom comments in The Deal Pipeline on novel investor litigation claiming warrant adjustment.
-
October 23, 2014
John D. Hogoboom is quoted in The Deal Pipeline in connection with dispute between Hudson Bay Capital Management LP and Worlds Inc. over the patent monetization company's refusal to lower the price of warrants issued last year in a private placement of convertible debt.
-
September 9, 2014
John D. Hogoboom comments on the current state of the market for life science IPOs in The Deal Pipeline's DealFlow Report.
-
July 11, 2014
In The Deal Pipeline, John D. Hogoboom comments on market dynamics affecting offerings by life science companies.
-
May 2014
Brooke A. Gillar has been named among The M&A Advisor's "40 Under 40" in the Legal Advisor category. The M&A Advisor recognizes professionals under the age of 40 for their accomplishments and expertise in M&A, financing, and turnarounds.